Company
Every investor coverage indicates participated in a round Felix Pharma raised.
Companies Felix Pharma acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Felix Pharma. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Advent International is to take a majority holding in trans-Tasman clinical trials operator NZCR, whose existing backers, among them Waterman Capital, will keep a minority position, with a fourth-quarter close anticipated.
Also adventinternational.com·nzcr.co.nz·biospectrumasia.com·healthcaredealflow.com
Square Peg's podcast interviews Aconex co-founders Leigh Jasper and Robert Phillpot about building the construction collaboration platform, its 2014 ASX listing, and its 2018 acquisition by Oracle for A$1.6 billion.
Also SmartCompany·SmartCompany